This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Vanderbilt University. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2025
Title: Subrata Shaw: Innovator in Cancer Treatment
Introduction
Subrata Shaw is a prominent inventor based in Nashville, TN (US), known for his significant contributions to the field of cancer treatment. With a focus on developing innovative compounds, he has made strides in the pharmaceutical industry, particularly in targeting specific proteins associated with cancer.
Latest Patents
Shaw holds 5 patents, with his latest inventions centered around substituted indole Mcl-1 inhibitors. These compounds are designed to inhibit the activity of the anti-apoptotic Bcl-2 family member Myeloid cell leukemia-1 (Mcl-1) protein. The inventions also encompass pharmaceutical compositions and methods for treating diseases characterized by the over-expression or dysregulation of Mcl-1 protein, such as cancer.
Career Highlights
Shaw is affiliated with Vanderbilt University, where he conducts research and develops his innovative solutions. His work has garnered attention for its potential impact on cancer therapies, showcasing his dedication to advancing medical science.
Collaborations
Some of his notable coworkers include Taekyu Lee and Zhiguo Bian, who contribute to the collaborative efforts in research and development at Vanderbilt University.
Conclusion
Subrata Shaw's work in developing Mcl-1 inhibitors represents a significant advancement in cancer treatment, highlighting his role as an influential inventor in the pharmaceutical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile